Is Vivitrol Right for You?

Why it may be time for Vivitrol.


You never expected to become addicted, and recovery can be hard. But there is a non-addictive medication that may help.

Stop the cravings and significantly reduce the risk of relapse!

Benefits of Opioid-dependent and Alcohol-dependent patients participating in counseling plus VIVITROL:

  • It is a Non-narcotic, non-addictive medication for opiate/alcohol dependence
  • No withdrawal symptoms
  • More success “maintaining” complete abstinence
  • Non-discriminatory treatment option; widely accepted among sober living houses, residential treatment, out-patient treatment, drug-court and 12-step fellowships
  • Reduces cravings which decreases chances of relapse/overdose
  • Longer stays in treatment
  • Hassle free monthly shot; no daily pills, strips or weekly doctor visits
  • Not considered drug replacement therapy

You deserve a shot at meaningful, lasting sobriety. Call today to learn more

Studies have shown that opioid-dependent patients who received counseling and Vivitrol had significantly more days of complete abstinence, stayed in treatment longer, reported less craving, and were less likely to relapse to physical dependence.

What is Vivitrol?

(naltrexone for extended-release injectable suspension)Vivitrol is a non-addictive, non-narcotic medication.

It does not react aversely with alcohol. It reduces cravings, helps achieve abstinence and blunts the affects of alcohol euphoria. Vivitrol also blocks the effects of opiates and reduces the cravings for opiates.

Vivitrol appears to break the self destructive, vicious cycle in alcoholics whereby one drink leads to multiple. When comparing abstinence rates at 6 months as a measure of success, studies have shown that Vivitrol works about 3 times better than counseling alone.

Vivitrol is indicated for opioid dependence which is generally viewed as a more intractable disease than alcoholism. In a study which included counseling, (like what is provided by Dr. Simon), 901% of those on Vivitrol were abstinent for 19 weeks compared to 35% of those on placebo.

In addition to improving compliance, the drug has an anti-craving effect and what the FDA called an anti-relapse effect. Patients who “slipped” (which is defined as a brief relapse) were better able to get back to abstinence with Vivitrol.